Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

patients will have to source their own syringes for the injections. The move is an escalation of the battle between Lilly and Novo Nordisk in the fast-growing obesity drugs market, where Zepbound ...

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide ... Eli Lilly's rival obesity therapy Zepbound (tirzepatide), which helped ...

Its lineup features several blockbusters, including its popular diabetes and weight loss medicines, Mounjaro and Zepbound. It's true that these drugs' sales are not increasing quite as fast as ...

Zepbound, another weight-loss drug, was taken off the compounding list in December after manufacturer Eli Lilly increased production. The same is expected to happen soon for Wegovy, which is made ...

Eli Lilly has begun the week with a bang. Early Monday morning, AdvanCell and OliX Pharmaceuticals put out news that the Big Pharma is coughing up cash to work with them on radiopharmaceuticals ...

In Q4 2024, the company saw a 45% increase in revenue, reaching $13.53 billion, driven by strong volume growth from Mounjaro and Zepbound. Earnings per share (EPS) for the quarter doubled ...

One couple in California described traveling out of town for their injections, telling no one ... who has lost 60 pounds on Zepbound, described how it felt to be out in public as a couple when ...

Your local pharmacy might be the next front in Donald Trump’s trade war. The president has in recent weeks promised to impose tariffs on all foreign-made medications, a move intended to ...

Are you a print subscriber? Activate your account. By Tim Nudd - 14 min 58 sec ago 2 hours 35 min ago By Parker Herren - 2 hours 48 min ago By Brian Bonilla - 2 hours 48 min ago By Jean-Paul ...

Pharmaceutical companies have introduced cost-reduction initiatives, such as Eli Lilly’s program offering Zepbound at $399 for a four-week supply. Some medical providers work with specific ...

Past studies have found a potential link between semaglutide and the eye condition called nonarteritic anterior ischemic optic neuropathy (NAION). A recently-published investigatory review reports ...